Defiance ETFs announced the launch of a new exchange-traded fund (ETF) designed to provide leveraged, inverse exposure to Eli Lilly and Company (LLY) stock. The fund, Defiance Daily Target 2X Short LLY ETF (LLYZ), aims to deliver daily returns that are the inverse of LLY’s daily performance, multiplied by two.
This structure allows retail investors to bet against Eli Lilly without the need for a margin account, a feature often required for similar leveraged trading strategies. However, this increased leverage also significantly magnifies risk.
The fund uses derivatives like swaps and options to achieve its investment objectives. Defiance emphasized that the fund is not a direct investment in Eli Lilly itself and is not suitable for all investors.
Defiance, founded in 2018, positions itself as a leader in thematic, income, and leveraged ETFs. The company highlighted its history of innovation in the ETF space and its commitment to providing investors with tools for amplified exposure to specific companies.
Investors considering LLYZ should carefully review the fund’s prospectus, which details investment objectives, risks, and expenses. The company stressed the importance of understanding the potential for significant losses, particularly given the fund’s daily leveraged inverse strategy.
The fund’s prospectus also explicitly cautions investors against using LLYZ for periods longer than a single day. The fund’s daily target could lead to significant divergence from the underlying asset’s performance over longer timeframes. Furthermore, investors could lose their entire principal within a single day.
Defiance warned that the fund is only appropriate for sophisticated investors who understand the inherent risks associated with leveraged, inverse trading strategies and who plan to actively monitor their investments. The fund’s investment strategy is subject to various risks, including those related to the underlying security’s performance, the pharmaceutical industry, derivatives, leverage, and liquidity.
The fund’s investment advisor is Tidal Investments, LLC. Defiance ETFs LLC serves as the ETF sponsor, and Foreside Fund Services, LLC distributes the fund. Interested investors can obtain a hard copy of the fund’s prospectus by contacting Defiance directly.
Related
